147 related articles for article (PubMed ID: 17915131)
1. [Utility of amylase levels in malignant pleural effusions].
Haro-Estarriol M; Casamitjá-Sot MT; Alvarez-Castillo LA; Calderón-López JC; Martínez-Somolinos S; Sebastián-Quetglas F
Med Clin (Barc); 2007 Sep; 129(10):372-4. PubMed ID: 17915131
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of amylase-rich pleural effusions with special reference to amylase isoenzyme analysis.
Joseph J; Viney S; Beck P; Strange C; Sahn SA; Basran GS
Chest; 1992 Nov; 102(5):1455-9. PubMed ID: 1385051
[TBL] [Abstract][Full Text] [Related]
3. [Cytological, biochemical and immunologic parameters of pleural effusions. Presentation of differences in relation to the nature of the effusion].
Kruszewski J; Płusa T; Maleszka P
Pneumonol Alergol Pol; 1991; 59(7-8):47-50. PubMed ID: 1843634
[TBL] [Abstract][Full Text] [Related]
4. [Vascular endothelial growth factor in benign and malignant pleural effusions].
Kaya A; Poyraz B; Celik G; Ciledag A; Gulbay BE; Savas H; Savas I
Arch Bronconeumol; 2005 Jul; 41(7):376-9. PubMed ID: 16029730
[TBL] [Abstract][Full Text] [Related]
5. Relationships between pleural fluid pH, PCO2 to pleural fluid PO2, amylase, protein, glucose and white cells in tuberculous and malignant effusions.
Limthongkul S; Charoenlap P; Nuchprayoon C; Songkhla YN
J Med Assoc Thai; 1990 Aug; 73(8):429-32. PubMed ID: 1702135
[TBL] [Abstract][Full Text] [Related]
6. Routine measurement of pleural fluid amylase is not indicated.
Branca P; Rodriguez RM; Rogers JT; Ayo DS; Moyers JP; Light RW
Arch Intern Med; 2001 Jan; 161(2):228-32. PubMed ID: 11176736
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor in malignant and tuberculous pleural effusions.
Lim SC; Jung SI; Kim YC; Park KO
J Korean Med Sci; 2000 Jun; 15(3):279-83. PubMed ID: 10895968
[TBL] [Abstract][Full Text] [Related]
8. Differences in Pleural Fluid Amylase Levels in Patients with Malignant Pleural Effusion Based on Cancer Type, Histologic Type, and Epidermal Growth Factor Receptor Mutations.
Shimoda M; Tanaka Y; Morimoto K; Yoshimori K; Ohta K
Intern Med; 2023 Dec; 62(24):3601-3607. PubMed ID: 37081679
[TBL] [Abstract][Full Text] [Related]
9. Etiology and pleural fluid characteristics of large and massive effusions.
Porcel JM; Vives M
Chest; 2003 Sep; 124(3):978-83. PubMed ID: 12970026
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin is upregulated in malignant and inflammatory pleural effusions.
Moschos C; Porfiridis I; Psallidas I; Kollintza A; Stathopoulos GT; Papiris SA; Roussos C; Kalomenidis I
Respirology; 2009 Jul; 14(5):716-22. PubMed ID: 19476604
[TBL] [Abstract][Full Text] [Related]
11. Etiology and prognostic significance of massive pleural effusions.
Jiménez D; Díaz G; Gil D; Cicero A; Pérez-Rodríguez E; Sueiro A; Light RW
Respir Med; 2005 Sep; 99(9):1183-7. PubMed ID: 16085221
[TBL] [Abstract][Full Text] [Related]
12. Differentiating tuberculous from malignant pleural effusions: a scoring model.
Porcel JM; Vives M
Med Sci Monit; 2003 May; 9(5):CR175-80. PubMed ID: 12761453
[TBL] [Abstract][Full Text] [Related]
13. Determination of tissue polypeptide-specific antigen in pleural fluid and serum from patients with pleural effusion.
Villena V; Echave-Sustaeta J; Lopez-Encuentra A; Martin-Escribano P; Estenoz-Alfaro J; Ortuño-de-Solo B
Int J Biol Markers; 1995; 10(3):161-5. PubMed ID: 8551059
[TBL] [Abstract][Full Text] [Related]
14. High level of vascular endothelial growth factor in hemorrhagic pleural effusion of cancer.
Ishimoto O; Saijo Y; Narumi K; Kimura Y; Ebina M; Matsubara N; Asou N; Nakai Y; Nukiwa T
Oncology; 2002; 63(1):70-5. PubMed ID: 12187074
[TBL] [Abstract][Full Text] [Related]
15. Amylase levels in pleural effusions: a consecutive unselected series of 841 patients.
Villena V; Pérez V; Pozo F; López-Encuentra A; Echave-Sustaeta J; Arenas J; Escribano PM
Chest; 2002 Feb; 121(2):470-4. PubMed ID: 11834659
[TBL] [Abstract][Full Text] [Related]
16. Potential diagnostic value of methylation profile in pleural fluid and serum from cancer patients with pleural effusion.
Benlloch S; Galbis-Caravajal JM; Martín C; Sanchez-Paya J; Rodríguez-Paniagua JM; Romero S; Mafe JJ; Massutí B
Cancer; 2006 Oct; 107(8):1859-65. PubMed ID: 16983705
[TBL] [Abstract][Full Text] [Related]
17. Elevated level of carcinoembryonic antigen in nonmalignant pleural effusions.
Garcia-Pachon E; Padilla-Navas I; Dosda MD; Miralles-Llopis A
Chest; 1997 Mar; 111(3):643-7. PubMed ID: 9118701
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic usefulness of tumour marker levels in pleural effusions of malignant and benign origin.
Kuralay F; Tokgöz Z; Cömlekci A
Clin Chim Acta; 2000 Oct; 300(1-2):43-55. PubMed ID: 10958862
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
Klech H; Rona G; Hutter C; Bayer PM; Kummer F
Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
[TBL] [Abstract][Full Text] [Related]
20. Mechanism for the recruitment of macrophages to cancer site. In vivo concentration gradient of monocyte chemotactic activity.
Martinet N; Beck G; Bernard V; Plenat F; Vaillant P; Schooneman F; Vignaud JM; Martinet Y
Cancer; 1992 Aug; 70(4):854-60. PubMed ID: 1379511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
